Commerzbank Aktiengesellschaft FI acquired a new stake in PerkinElmer, Inc. (NYSE:PKI) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,780 shares of the medical research company’s stock, valued at approximately $468,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Ontario Teachers Pension Plan Board raised its position in shares of PerkinElmer by 36.3% in the second quarter. Ontario Teachers Pension Plan Board now owns 95,415 shares of the medical research company’s stock valued at $6,502,000 after purchasing an additional 25,404 shares during the period. Neuberger Berman Group LLC grew its stake in shares of PerkinElmer by 59.8% in the second quarter. Neuberger Berman Group LLC now owns 52,030 shares of the medical research company’s stock valued at $3,545,000 after acquiring an additional 19,464 shares in the last quarter. Bessemer Group Inc. grew its stake in shares of PerkinElmer by 22.2% in the third quarter. Bessemer Group Inc. now owns 27,149 shares of the medical research company’s stock valued at $1,873,000 after acquiring an additional 4,936 shares in the last quarter. Legal & General Group Plc grew its stake in shares of PerkinElmer by 13.0% in the second quarter. Legal & General Group Plc now owns 100,010 shares of the medical research company’s stock valued at $6,815,000 after acquiring an additional 11,530 shares in the last quarter. Finally, State of Wisconsin Investment Board acquired a new position in shares of PerkinElmer in the third quarter valued at about $1,673,000. 91.66% of the stock is currently owned by institutional investors.

Several research firms recently commented on PKI. ValuEngine downgraded shares of PerkinElmer from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Morgan Stanley upped their price target on shares of PerkinElmer from $77.00 to $78.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Robert W. Baird upped their price target on shares of PerkinElmer from $75.00 to $78.00 and gave the company an “outperform” rating in a research note on Friday, November 3rd. Jefferies Group restated a “hold” rating and issued a $70.00 price target on shares of PerkinElmer in a research note on Friday, October 20th. Finally, Goldman Sachs Group restated a “neutral” rating and issued a $67.00 price target on shares of PerkinElmer in a research note on Tuesday, September 26th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and six have given a buy rating to the company’s stock. PerkinElmer currently has an average rating of “Hold” and an average price target of $68.64.

Shares of PerkinElmer, Inc. (PKI) traded up $0.92 during trading on Monday, reaching $71.03. 760,500 shares of the company’s stock were exchanged, compared to its average volume of 633,304. The firm has a market capitalization of $7,829.29, a P/E ratio of 25.55, a price-to-earnings-growth ratio of 2.12 and a beta of 0.77. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.59 and a quick ratio of 2.09. PerkinElmer, Inc. has a 12-month low of $50.59 and a 12-month high of $74.11.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be paid a dividend of $0.07 per share. The ex-dividend date is Thursday, January 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.39%. PerkinElmer’s payout ratio is 7.78%.

In other PerkinElmer news, Director Alexis P. Michas sold 5,000 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $73.18, for a total transaction of $365,900.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Frank Anders Wilson sold 37,535 shares of the stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $70.14, for a total transaction of $2,632,704.90. The disclosure for this sale can be found here. Insiders have sold 73,656 shares of company stock worth $5,201,957 over the last quarter. Corporate insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/commerzbank-aktiengesellschaft-fi-invests-468000-in-perkinelmer-inc-pki/1757814.html.

PerkinElmer Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.